Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

• Ngā kaituhi matua: Paolo Gaibani (Author), Tommaso Giani (Author), Federica Bovo (Author), Donatella Lombardo (Author), Stefano Amadesi (Author), Tiziana Lazzarotto (Author), Marco Coppi (Author), Gian Maria Rossolini (Author), Simone Ambretti (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Multidrug resistance (MDR) represents a serious global threat due to the rapid global spread and limited antimicrobial options for treatment of difficult-to-treat (DTR) infections sustained by MDR pathogens. Recently, novel β-lactams/β-lactamase inhibitor combinations (βL-βLICs) have been developed...